Combined Expression of Plasma Thrombospondin‐2 and CA19‐9 for Diagnosis of Pancreatic Cancer and Distal Cholangiocarcinoma: A Proteome Approach

BACKGROUND: Minimally invasive diagnostic biomarkers for patients with pancreatic ductal adenocarcinoma (PDAC) and distal cholangiocarcinoma (dCCA) are warranted to facilitate accurate diagnosis. This study identified diagnostic plasma proteins based on proteomics of tumor secretome. MATERIALS AND M...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncologist
Autors principals: Le Large, Tessa Y.S., Meijer, Laura L., Paleckyte, Rosita, Boyd, Lenka N.C., Kok, Bart, Wurdinger, Thomas, Schelfhorst, Tim, Piersma, Sander R., Pham, Thang V., van Grieken, Nicole C.T., Zonderhuis, Barbara M., Daams, Freek, van Laarhoven, Hanneke W.M., Bijlsma, Maarten F., Jimenez, Connie R., Giovannetti, Elisa, Kazemier, Geert
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2020
Matèries:
Cancer Diagnostics and Molecular Pathology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7160420/
https://ncbi.nlm.nih.gov/pubmed/31943574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0680
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars